Literature DB >> 22127923

STK33 kinase is not essential in KRAS-dependent cells--letter.

Stefan Fröhling, Claudia Scholl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22127923     DOI： 10.1158/0008-5472.CAN-11-2495

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

Review 1.  Lessons learned from radiation oncology clinical trials.

Authors:  Fei-Fei Liu; Paul Okunieff; Eric J Bernhard; Helen B Stone; Stephen Yoo; C Norman Coleman; Bhadrasain Vikram; Martin Brown; John Buatti; Chandan Guha
Journal:  Clin Cancer Res       Date:  2013-09-16       Impact factor: 12.531

Review 2.  Synthetic Lethal Vulnerabilities in KRAS-Mutant Cancers.

Authors:  Andrew J Aguirre; William C Hahn
Journal:  Cold Spring Harb Perspect Med       Date:  2018-08-01       Impact factor: 6.915

Review 3.  RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?

Authors:  Julian Downward
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

4.  The serine/threonine kinase 33 is present and expressed in palaeognath birds but has become a unitary pseudogene in neognaths about 100 million years ago.

Authors:  Tobias Lautwein; Steffen Lerch; Daniel Schäfer; Erwin R Schmidt
Journal:  BMC Genomics       Date:  2015-07-22       Impact factor: 3.969

5.  Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility.

Authors:  Angel A Ku; Hsien-Ming Hu; Xin Zhao; Khyati N Shah; Sameera Kongara; Di Wu; Frank McCormick; Allan Balmain; Sourav Bandyopadhyay
Journal:  Nat Commun       Date:  2020-05-12       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.